Multi-site trials rely on experienced remote monitors to coordinate their activities and communications, but that doesn’t mean the individual sites can slack off. The absence of face-to-face communication can magnify seemingly simple errors, a veteran trial monitor warns. Barbara Winter,…
Microsoft builds a bot to match patients to clinical trials
Patients, sometimes desperately sick, find it hard to comb through the roughly 50,000 clinical trials worldwide and their arcane and lengthy criteria. That’s where the the Clinical Trials Bot can help. A chat bot that began as a hackathon project at Microsoft’s…
Strength in numbers: Because having a rare disease isn’t rare
Rare doesn’t mean insignificant – in fact more people live with a rare disease than with cancer and AIDS combined. A decade after personal experience prompted her to found Global Genes, Nicole Boice tells Deep Dive that rare diseases need…
How pharma can support doctors who treat rare diseases
Where do doctors see patients with rare diseases, how do they keep up with treatment advances and what can pharmaceutical companies do to help? Those were just some of the questions addressed by exclusive research carried out by Cambridge,…
Could talking to patients be the biggest innovation in clinical trial recruitment?
This artcile was first published in March 2019 and is written by Havas Lynx Faze, a specialist patient recruitment and engagement agency focused on delivering better patient experiences within clinical trials’ 80% of trials are failing to recruit the required…
Government may drop clinical trials of orphan drugs
Orphan drugs are medicines used in the treatment of rare diseases with less than five lakh patients in a country, but are believed to be expensive. Published: 27th February 2019 07:48 AM | Last Updated: 27th February 2019 07:59 AM…
Indian biosimilar market to be worth $40 billion by 2030
The Confederation of Indian Industry (CII) & Sathguru Management Consultants released a position paper on Indian Biosimilars Industry. “Indian Biosimilars Industry: Roadmap to Actualize Global Leadership” at the 2nd National Biotechnology Conclave 2018 – Driving Inclusive Growth for Indian Bio-economy…
German Regulators: 1,300 Trials Imperiled by “Hard” Brexit
Some 1,300 trials in the UK may have to stop their work if the UK leaves the EU without some kind of new regulatory regime in place, officials at Germany’s Federal Institute for Drugs and Medical Devices say in a…
Three Reasons Why Mobile Technology Is A Secret Weapon For Patient Engagement And Study Success
The use of mobile technology in clinical trials is becoming increasingly prevalent, most notably in collecting electronic clinical outcome assessment (eCOA) data. Its role, however, in improving patient engagement throughout an entire study is a lesser known area, and an…
Patients Are Eager for Trials But Aren’t Getting the Word, Survey Finds
Patients are eager to participate in clinical trials, but they’re having trouble finding the information they need — not just on social media, but from their own doctors, a new survey suggests. Many respondents said they’d be interested in joining…
